Cholesterol drug studied as abortion pill alternative
NCT ID NCT05342974
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested whether the cholesterol drug atorvastatin, followed by misoprostol, can safely and effectively end an early pregnancy. Nine participants at 35-49 days of pregnancy took atorvastatin daily for a week, then misoprostol. Researchers used ultrasounds and blood tests to see if the pregnancy stopped or passed. The study is complete, but results are not yet reported.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- atorvastatin and misoprostol
- What this could lead to
- If it works, this could point toward a new medication abortion option without mifepristone.
- What could go wrong
- This is a very small, early-phase pilot study with only 9 participants. It may not work, and participants may still need a surgical procedure to complete the abortion.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABORTION EARLY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Planned Parenthood Association of Utah
Salt Lake City, Utah, 84102, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.